skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Tiotropium Respimat® improves physical functioning in chronic obstructive pulmonary disease

Original Research

(1506) Views  (789) Full article downloads

Authors: Heike Rau-Berger, Harald Mitfessel, Thomas Glaab

Published Date October 2010 Volume 2010:5 Pages 367 - 373
DOI: http://dx.doi.org/10.2147/COPD.S14082

Heike Rau-Berger1, Harald Mitfessel2, Thomas Glaab1
1Medical Affairs Germany, Respiratory Medicine, Boehringer Ingelheim Pharma GmbH and Co. KG, Ingelheim; 2Pulmonology Practice, Remscheid, Germany

Aim: This observational study with tiotropium Respimat® was performed in a real-life setting to investigate its effectiveness with regard to physical functioning and tolerability.
Methods: Patients with chronic obstructive pulmonary disease (COPD; n = 1,230; mean age, 65.5 years) received tiotropium 5 µg once daily via Respimat® Soft Inhaler for 6 weeks in an open-label observational study. At baseline and week 6, patients completed the Physical Function subdomain [PF-10] of the Short Form (SF) 36 questionnaire.
Results: Improvement in standardized PF-10 score of ≥10 points was achieved by 61.5% of patients. Mean (SD) standardized PF-10 scores improved by 13.4 (15.9) points, from 49.0 (24.5) to 62.3 points (23.5; P < 0.001). Results in smokers (n = 435) were not significantly different to those in nonsmokers. The general condition of patients improved during treatment. Adverse events were reported by 4.0% of patients and were chiefly respiratory symptoms and dry mouth.
Conclusion: In COPD patients receiving tiotropium Respimat® in daily practice, physical function improved rapidly within 6 weeks of treatment, irrespective of smoking status.

Keywords: COPD, tiotropium, physical function, therapy






Readers of this article also read:

An overview of the benefits and drawbacks of inhaled corticosteroids in chronic obstructive pulmonary disease
COPD is frequent in conditions of comorbidity in patients treated with various diseases in a university hospital
Direct costs of chronic obstructive pulmonary disease among managed care patients
Budesonide/formoterol combination in COPD: a US perspective
Development and implementation of treadmill exercise testing protocols in COPD
Improving adherence with inhaler therapy in COPD
Sustained effects of integrated COPD management on health status and exercise capacity in primary care patients
In search of parsimony: reliability and validity of the Functional Performance Inventory-Short Form
Association between lung function and exacerbation frequency in patients with COPD
Adherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroids
  • Journal Indexing

    See where all the Dove Press journals are indexed

  • Testimonials

    "You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio